Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: Results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database

American Journal of Kidney Diseases

Volumn 59, Issue 1, 2012, Pages 75-83

  Packham, David K ^a   Alves, Tahira P ^b   Dwyer, Jamie P ^c   Atkins, Robert ^d   De Zeeuw, Dick ^e   Cooper, Mark ^f   Shahinfar, Shahnaz ^g   Lewis, Julia B ^c   Lambers Heerspink, Hiddo J ^e  

^a AUSTIN HOSPITAL   (Australia)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

cardiovascular mortality; Diabetes Mellitus Treatment for Renal Insufficiency Consortium (DIAMETRIC); end stage renal disease; Type 2 diabetic nephropathy

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST;

ADULT; AGED; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; DATA BASE; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; RETROSPECTIVE STUDY;

CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROTEINURIA; RETROSPECTIVE STUDIES;

EID: 83655201254     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.09.017     Document Type: Article

References (31)

1. E. Ritz, S.R. Orth Nephropathy in patients with type 2 diabetes mellitus N Engl J Med 341 15 1999 1127 1133
2. rd ed. 2006 International Diabetes Federation Brussels, Belgium
3. R. Huxley, F. Barzi, M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 7533 2006 73 78
4. M. Woodward, X. Zhang, F. Barzi The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region Diabetes Care 26 2 2003 360 366
5. A.E. Raine The rising tide of diabetic nephropathythe warning before the flood? Nephrol Dial Transplant 10 4 1995 460 461
6. Y. Suzuki, M. Arakawa The treatment of the uraemic diabetic Are we doing enough? A view from Japan. Fumitake Gejyo and Collaborate Study Group Nephrol Dial Transplant 10 suppl 7 1995 47 55
7. US Renal Data System USRDS Annual Data Report 1994: Atlas of End-Stage Renal Disease in the United States 1995 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
8. A.I. Adler, R.J. Stevens, S.E. Manley, R.W. Bilous, C.A. Cull, R.R. Holman Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 1 2003 225 232
9. A.J. Collins, B. Kasiske, C. Herzog Excerpts from the United States Renal Data System 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States Am J Kidney Dis 45 suppl 1 2005 A5 A7 (1) S1-S280
10. N. Ismail, B. Becker, P. Strzelczyk, E. Ritz Renal disease and hypertension in non-insulin-dependent diabetes mellitus Kidney Int 55 1 1999 1 28
11. J.P. Vora, H.A.A. Ibrahim Clinical manifestations and natural history of diabetic nephropathy R. Johnson, J. Feehally, Comprehensive Clinical Nephrology 2003 Mosby Philadelphia, PA 425 433
12. D.S. Keith, G.A. Nichols, C.M. Gullion, J.B. Brown, D.H. Smith Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 6 2004 659 663
13. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Hypertension 42 5 2003 1050 1065
14. R.N. Foley, P.S. Parfrey, M.J. Sarnak Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 suppl 3 1998 S112 S119 (5)
15. B.L. Kasiske, R.S. Kalil, J.Z. Ma, M. Liao, W.F. Keane Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis Ann Intern Med 118 2 1993 129 138
16. P. Weidmann, L.M. Boehlen, M. de Courten Effects of different antihypertensive drugs on human diabetic proteinuria Nephrol Dial Transplant 8 7 1993 582 584
17. E.J. Lewis, L.G. Hunsicker, R.P. Bain, R.D. Rohde The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy The Collaborative Study Group N Engl J Med 329 20 1993 1456 1462
18. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 12 2001 851 860
19. B.M. Brenner, M.E. Cooper, D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 12 2001 861 869
20. T.P. Alves, X. Wang, J.T. Wright Jr Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis J Am Soc Nephrol 21 8 2010 1361 1369
21. R.A. Rodby, R.D. Rohde, W.R. Clarke The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics For the Collaborative Study Group Nephrol Dial Transplant 15 4 2000 487 497
22. B.M. Brenner, M.E. Cooper, D. de Zeeuw The losartan renal protection studyrationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) J Renin Angiotensin Aldosterone Syst 1 4 2000 328 335
23. J. Lewis, L. Agodoa, D. Cheek Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate Am J Kidney Dis 38 4 2001 744 753
24. W.Y. So, A.P. Kong, R.C. Ma Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients Diabetes Care 29 9 2006 2046 2052
25. B.B. Newsome, W.M. McClellan, J.J. Allison Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction Am J Kidney Dis 52 2 2008 251 261
26. M.A. Pfeffer, E.A. Burdmann, C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 21 2009 2019 2032
27. T. Ninomiya, V. Perkovic, B.E. de Galan Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes J Am Soc Nephrol 20 8 2009 1813 1821
28. R.J. MacIsaac, C. Tsalamandris, S. Panagiotopoulos, T.J. Smith, K.J. McNeil, G. Jerums Nonalbuminuric renal insufficiency in type 2 diabetes Diabetes Care 27 1 2004 195 200
29. V. Rigalleau, C. Lasseur, C. Raffaitin Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group Diabetes Care 30 8 2007 2034 2039
30. I. Ledebo, M. Kessler, W. van Biesen Initiation of dialysisopinions from an international survey: report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 18 September 2000, Nice Nephrol Dial Transplant 16 6 2001 1132 1138
31. National Kidney Foundation DOQI Clinical Practice Guidelines for Hemodialysis Adequacy Am J Kidney Dis 30 3 1997 1